Exploring isoxazoles and pyrrolidinones decorated with the 4,6‐dimethoxy‐1,3,5‐triazine unit as human farnesyltransferase inhibitors-Reference-Cited by-同舟云学术

Exploring isoxazoles and pyrrolidinones decorated with the 4,6‐dimethoxy‐1,3,5‐triazine unit as human farnesyltransferase inhibitors

Published:2019-04-04 Issue:5 Volume:352 Page:1800227
ISSN:0365-6233
Container-title:Archiv der Pharmazie
language:en
Short-container-title:Arch Pharm Chem Life Sci

Author:

Lucescu Liliana¹,Ghinet Alina¹²³^ORCID,Shova Sergiu⁴,Magnez Romain⁵,Thuru Xavier⁵,Farce Amaury²⁶,Rigo Benoît²³,Belei Dalila¹,Dubois Joëlle⁷,Bîcu Elena¹

Affiliation:

1. Faculty of ChemistryAl. I. Cuza' University of IasiIasi Romania

2. Inserm U995, LIRIC, Faculté de médecine—Pôle rechercheUniversité de Lille, CHRU de LilleLille France

3. Laboratoire de Chimie Durable et SantéHautes Etudes d'Ingénieur (HEI), Yncréa Hauts‐de‐France, UC LilleLille France

4. Petru Poni' Institute of Macromolecular ChemistryIasi Romania

5. Univ. Lille, UMR‐S 1172 ‐ JPARC ‐ Centre de Recherche Jean‐Pierre AUBERT Neurosciences et CancerLille France

6. Faculté des Sciences Pharmaceutiques et Biologiques de LilleLille France

7. Centre de Recherche de GifInstitut de Chimie des Substances Naturelles, UPR2301 CNRSGif‐sur‐Yvette France

Funder

Integrated Center of Environmental Science Studies in the North East Region

Publisher

Wiley

Subject

Drug Discovery,Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ardp.201800227

Reference71 articles.

1. Farnesyltransferase inhibitor FTI-277 inhibits PD-L1 expression on septic spleen lymphocytes and promotes spleen lymphocyte activation

2. New tricks for human farnesyltransferase inhibitor: cancer and beyond

3. Ras—A Molecular Switch Involved in Tumor Formation

4. https://clinicaltrials.gov/(accessed: February 2019).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New indazole-indolizine-triazine hybrid molecules with farnesyltransferase inhibitory activity;Results in Chemistry;2024-01

2. FTase inhibitors and cancer: prospects for use in targeted therapies;Medicinal Chemistry Research;2023-12-09

3. Synthesis, characterization, and DFT study of the s-triazine analogues of medicinal interest incorporated with five- and six-membered bioactive heterocyclic scaffolds;Journal of Molecular Structure;2023-04

4. Synthesis of Benzalacetophenone-based Isoxazoline and Isoxazole Derivatives;Current Organic Chemistry;2022-04

5. Isoxazoles;Comprehensive Heterocyclic Chemistry IV;2022